Effective January 1, 2015, Nasonex^® will be removed from the Select Drug Program Formulary. This change will move the drug from tier 2 (formulary level of cost-sharing) to tier 3 (non-formulary level of cost-sharing). Additionally, Nasonex^® will require prior authorization. Generic intranasal corticosteroids, such as fluticasone, flunisolide and budesonide, are available at tier 1, the lowest level of cost-sharing, with no requirement for prior authorization. While there are over-the-counter (OTC) products available, they are not covered under the pharmacy benefit.

Please discuss the generic intranasal corticosteroid alternatives and the proper use of prescription and OTC products with your patients to determine the most appropriate plan of action.